Differential counts of leukocytes in mouse BALF. by Guoqing Meng (4669774)

Subjects:

Comparison of serum vitamin D and calcium levels in patients with stable and unstable intertrochanteric fractures included in this study. by Kamran Alijanpour (20314706)

Subjects:

Microscopic examination of M07 adhesion to Caco-2 cells (400x). by Guoqing Meng (4669774)

Subjects:

Compressibility modulus of improved red clay. by Quan Shen (37564)

Subjects:

Viability of M07 after co-incubation with GI fluid (Log CFU/mL). by Guoqing Meng (4669774)

Subjects:

Experimental Design. by Quan Shen (37564)

Subjects:

Compressive strain of improved red clay. by Quan Shen (37564)

Subjects:

Tuning the Upper Critical Solution Temperature of the Polystyrene-Terpineol System toward a Low-Temperature Membrane Formation by Sulaiman Dhameri (22048528)

Subjects:

Unconfined Compressive Strength of Improved Red Clay. by Quan Shen (37564)

Subjects:

Schematic of the OVA-induced asthma mouse model protocol. by Guoqing Meng (4669774)

Subjects:

Field Site of Red Clay Subgrade Diseases in Zhuzhou. by Quan Shen (37564)

Subjects:

EMI of 0.25% Roadyes-treated red clay after failure. by Quan Shen (37564)

Subjects:

Levels of pro- and anti-inflammatory cytokines in BALF. by Guoqing Meng (4669774)

Subjects:

Representative sections of HE-stained lung tissue from different groups under light microscopy(400X). by Guoqing Meng (4669774)

Subjects:

Four grid table. by Xiaoling Zhong (181270)

Subjects:

Flowchart depicting the selection of the study population. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the PT level (age < 18). by Xiaoling Zhong (181270)

Subjects:

Basic information and patient characteristics according to the report. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the preferred term level in the FAERS database. by Xiaoling Zhong (181270)

Subjects:

Four major algorithms used for signal detection. by Xiaoling Zhong (181270)

Subjects: